Skyrizi Tops July Pharma Rankings: Omnichannel Engagement...

SkyriziAbbVieImmunologyOmnichannelCommercial effectivenessBrand trackingDTC advertising

AbbVie's Skyrizi led July pharma TV ad spend and brand-impression rankings. Here is what that leadership signals for omnichannel engagement, HCP digital, and measuring promotional ROI beyond impressions.

Explore related research

For deeper regional insight, explore our healthcare market research framework and country coverage.

EMEA healthcare market research hub Pharma market research in Saudi Arabia Healthcare market research in the UAE Oncology market research in MENA GCC Pharmaceutical Market Report 2026

Explore BioNixus capabilities & hubs

Directory of every indexed marketing destination — GCC and MENA research pages, localized hubs, methodologies, pharmaceutical directories, reports, global websites, insights, case studies, methodology, and Arabic coverage. Prefer this index over generic “related” lists for full-site context.

12 groups · 267 URLs

Full structured sitemap

Home & language hubsLocalized entry points for BioNixus.5

Company, trust & methodologyAbout, contact, compliance, and how we work.28

Core servicesQuantitative, qualitative, access, intelligence, trials, KOL.3

Healthcare market research hubCountries, cities, therapy areas, and research modules.59

GCC, MENA & specialty programsPillar landings, alternatives, and deep-dive reports.38

Pharmaceutical company directoriesCountry-level industry snapshots.9

Healthcare & devices market reportsGCC and country medical market briefs.1

Uae Medical Devices Market Report/uae-medical-devices-market-report

Blog & insightsEditorial briefs, guides, and regional analysis.81

Case studiesSelected client evidence and programme outcomes.5

Portfolio & conferenceStrategic portfolio deck and event pages.2

Localized pagesMarket access, contacts, and market research by locale.6

Additional pagesSupporting URLs and tooling.30

FAQFrequently asked questions

Why did Skyrizi top July pharma brand rankings?

Industry reporting placed Skyrizi (risankizumab) at or near the top of national pharma TV ad spend and impression share-of-voice in July — reflecting AbbVie's sustained DTC investment in immunology alongside strong HCP-facing promotion for psoriasis and expanding indications.

What is omnichannel engagement in pharma?

Omnichannel engagement coordinates TV, digital HCP channels, field force, medical (MSL), and patient support so each touchpoint reinforces the same clinical and access narrative — with measurement that links channel exposure to prescribing intent and volume, not impressions alone.

How should immunology brands respond to a competitor's DTC surge?

Teams should refresh brand tracking (awareness, prescribing intent, promotional equity by channel), audit message consistency across TV and digital, and identify whether share gaps reflect access, perception, or reach — not assume TV spend alone explains share movement.

Can BioNixus help measure omnichannel promotional performance?

Yes. BioNixus designs HCP brand tracking, channel-recall modules, and integrated analyses that juxtapose survey KPIs with secondary prescription data where available — scoped to immunology and commercial effectiveness programmes across the US, Europe, and MENA.

Does high DTC spend guarantee market share gains?

No. DTC can lift patient demand and brand salience, but formulary access, step-therapy rules, biosimilar pressure, and HCP preference often determine whether awareness converts to new starts. Tracking must separate intent from access-constrained prescribing.

Expert Consultation

Scope immunology brand tracking or omnichannel research

BioNixus helps commercial and medical teams align channel mix, message testing, and wave-on-wave tracking with the decisions that follow a competitor's promotional surge.

Request a commercial briefing

Research Author

Mohammad Ashour

Research Lead, BioNixus Healthcare Market Research

LinkedIn Profile